These effects may exacerbate the insulin resistant environment characteristic of pregnancy, causing severe insulin resistance in skeletal muscle, liver, and adipose tissue, ultimately reducing the compensatory effects of pancreatic β-cells and leading to the development of GDM. This evidence concerns the gene INS and gestational diabetes.